Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD). 

Biotechnology

Vanqua Bio

Vanqua Bio's headquarters in Chicago, IL, United States

Jim Sullivan

Jesse Cedarbaum

Omer Siddiqui

Jack Beyer

Bernard Davitian

Mona Ashiya

Sara Nayeem

Dimitri Krainc

James B. Summers

Gregory Grabowski

Jonathan Silverstein

Rand Sutherland

Description

People (19)

Jim Sullivan

Jack Beyer

Daniel Ysselstein

Jianbin Zheng

Carole Deyts

Catherine Lammert

Cynthia Martinez

Eric Zluhan

Gregory Sheyka

Haneen Ammouri

Jennifer Yuanshih Hu

Maria Nguyen

Nikki Huynh

Paola Carrillo

Sida Shen

Shivani Agarwal

Thu (Mi) Nguyen

Nina Pinelli

Caroline Chan

Jobs